Ara
Toplam kayıt 29, listelenen: 11-20
Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: An analysis of the CROES-UTUC registry
(Springer, 2022)
Background: The European Association of Urology provides Clinical Practice Guideline on upper tract urothelial carcinoma (UTUC). Due to the rarity of UTUC, guidelines are necessary to help guide decision-making based on ...
Molecular biomarkers in the context of focal therapy for prostate cancer: Recommendations of a delphi consensus from the focal therapy society
(Edizioni Minerva Medica, 2022)
BACKGROUND: Focal therapy (FT) for prostate cancer (PCa) is promising. However, long-term oncological results are awaited and there is no consensus on follow-up strategies. Molecular biomarkers (MB) may be useful in ...
Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: Current perspective and ongoing trials
(Springer, 2021)
Focal therapy is growing as an alternative management options for men with clinically localized prostate cancer. Parallel to the increasing popularity of active surveillance (AS) as a treatment for low-risk disease, there ...
Preservation of antegrade ejaculation after surgical relief of benign prostatic obstruction is a valid endpoint
(Springer, 2021)
Purpose To review the current data on retrograde ejaculation (RE) and ejaculatory dysfunction (EjD) after endoscopic and minimally invasive surgical treatment of benign prostatic obstruction (BPO) and, their perceived ...
Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma
(NLM (Medline), 2023)
BACKGROUND: The evidence of prognostic factors and individualized surveillance strategies for upper tract urothelial carcinoma are still weak. OBJECTIVES: To evaluate whether the history of previous malignancy (HPM) affects ...
A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.
(Wolters Kluwer Health, 2023)
To the Editor: We appreciate this opportunity toaddress the concerns in the comment by Jin et al on ourarticle,1evaluating the adverse events and quality of lifeafter irreversible electroporation (IRE) for the ablationof ...
Effect of focal vs extended irreversible electroporation for the ablation of localized low- or intermediate-risk prostate cancer on early oncological control: A randomized clinical trial
(American Medical Association, 2023)
Importance: Focal ablative irreversible electroporation (IRE) is a therapy that treats only the area of the tumor with the aim of achieving oncological control while reducing treatment-related functional detriment. Objective: ...
Segmental resection for ureter urothelial carcinoma is safe as radical nephroureterectomy
(Elsevier, 2023)
Introduction & Objectives: Kidney-sparing surgery (KSS) seems inferior to radical nephroureterectomy (RNU) in recurrence-free survival (RFS). However, there is limited data regarding the potential influence of the location ...
Flexible ureteroscopy for upper tract urothelial carcinoma
(Springer Nature, 2022)
Flexible ureteroscopy (fURS) is an essential tool for the diagnosis, risk stratification, and treatment of upper tract urothelial carcinoma (UTUC). fURS should actually be performed in case of uncertainty, for kidney-sparing ...
Turkish validation of the user version of the mobile application rating scale
(AVES, 2022)
Objective: As the number of mobile health applications increases, quality assessment becomes a capital feature of any mobile application design. Besides the professional evaluation conducted before marketing the app, the ...